首页 > 最新文献

European Journal of Vascular and Endovascular Surgery最新文献

英文 中文
European Society for Vascular Surgery 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases: a North American Perspective. 欧洲血管外科学会2026关于降胸和胸腹主动脉疾病管理的临床实践指南:北美视角。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 DOI: 10.1016/j.ejvs.2025.12.054
Matthew P Sweet, Sara L Zettervall
{"title":"European Society for Vascular Surgery 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases: a North American Perspective.","authors":"Matthew P Sweet, Sara L Zettervall","doi":"10.1016/j.ejvs.2025.12.054","DOIUrl":"https://doi.org/10.1016/j.ejvs.2025.12.054","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":"71 2","pages":"167-169"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological Considerations in Linking Kidney Function to Abdominal Aortic Aneurysm Risk. 将肾功能与腹主动脉瘤风险联系起来的方法学考虑。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-06-27 DOI: 10.1016/j.ejvs.2025.06.060
Yuhao Wang, Yingying Li, Jueying Chen
{"title":"Methodological Considerations in Linking Kidney Function to Abdominal Aortic Aneurysm Risk.","authors":"Yuhao Wang, Yingying Li, Jueying Chen","doi":"10.1016/j.ejvs.2025.06.060","DOIUrl":"10.1016/j.ejvs.2025.06.060","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"335"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Walking Dead Problem: Why Amputation Prediction Demands Competing Risk Models. 《行尸走肉》问题:为什么截肢预测需要竞争风险模型。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-10-25 DOI: 10.1016/j.ejvs.2025.10.030
Florian Englich, Lorenz Meuli
{"title":"The Walking Dead Problem: Why Amputation Prediction Demands Competing Risk Models.","authors":"Florian Englich, Lorenz Meuli","doi":"10.1016/j.ejvs.2025.10.030","DOIUrl":"10.1016/j.ejvs.2025.10.030","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"304-305"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bone Perforator Vein Leading to Varicose Veins. 导致静脉曲张的骨穿静脉。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-07-28 DOI: 10.1016/j.ejvs.2025.07.046
Fangshi Xu, Hui Wang
{"title":"Bone Perforator Vein Leading to Varicose Veins.","authors":"Fangshi Xu, Hui Wang","doi":"10.1016/j.ejvs.2025.07.046","DOIUrl":"10.1016/j.ejvs.2025.07.046","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"318"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iatrogenic Central Vein Perforation. 医源性中央静脉穿孔。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-10-03 DOI: 10.1016/j.ejvs.2025.09.061
Xian-Zheng Tan, Chong Chen
{"title":"Iatrogenic Central Vein Perforation.","authors":"Xian-Zheng Tan, Chong Chen","doi":"10.1016/j.ejvs.2025.09.061","DOIUrl":"10.1016/j.ejvs.2025.09.061","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"330"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145228670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Shunt for Bleeding Rectosigmoid Varices: Sigmoid Vein to Caval Bypass. 一种治疗直肠乙状结肠静脉曲张出血的新型分流方法:乙状结肠静脉至下腔静脉旁路。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-08-29 DOI: 10.1016/j.ejvs.2025.08.051
Basil Babu, Divij Jayant, Arunanshu Behera
{"title":"A Novel Shunt for Bleeding Rectosigmoid Varices: Sigmoid Vein to Caval Bypass.","authors":"Basil Babu, Divij Jayant, Arunanshu Behera","doi":"10.1016/j.ejvs.2025.08.051","DOIUrl":"10.1016/j.ejvs.2025.08.051","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"340-341"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological Concerns Regarding the Incidence Rates of Mesenteric Ischaemia. 关于肠系膜缺血发生率的方法学问题。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-07-29 DOI: 10.1016/j.ejvs.2025.07.041
Buyuan Dong, Lingyan Qiu
{"title":"Methodological Concerns Regarding the Incidence Rates of Mesenteric Ischaemia.","authors":"Buyuan Dong, Lingyan Qiu","doi":"10.1016/j.ejvs.2025.07.041","DOIUrl":"10.1016/j.ejvs.2025.07.041","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"336-337"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Pierced Aorta: Insights into Infrarenal Penetrating Aortic Ulcers. 穿透主动脉:对肾下穿透性主动脉溃疡的洞察。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-09-17 DOI: 10.1016/j.ejvs.2025.09.018
Tiago F Ribeiro
{"title":"The Pierced Aorta: Insights into Infrarenal Penetrating Aortic Ulcers.","authors":"Tiago F Ribeiro","doi":"10.1016/j.ejvs.2025.09.018","DOIUrl":"10.1016/j.ejvs.2025.09.018","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"281-282"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145093109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editor's Choice - Association Between Anatomical Patterns of Arterial Occlusive Disease and Endovascular Outcomes in the BEST-CLI Trial Supports the Use of the Global Limb Anatomic Staging System. BEST-CLI试验中动脉闭塞性疾病解剖模式与血管内预后的关联支持了全球肢体解剖分期系统的使用。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-10-24 DOI: 10.1016/j.ejvs.2025.10.039
Katharine L McGinigle, Matthew T Menard, Gheorghe Doros, Michael B Strong, Alik Farber, Michael S Conte

Objective: This study aimed to retrospectively apply a modified Global Limb Anatomic Staging System (GLASS) framework of infrainguinal arterial disease to patients enrolled in the Best Endovascular vs. Best Surgical Therapy in patients with Critical Limb Ischemia (BEST-CLI) trial to assess its validity for limb based outcomes and its utility in guiding the choice between endovascular therapy (ENDO) and open surgical bypass (OPEN).

Methods: This was a secondary analysis of the BEST-CLI clinical trial dataset. The BEST-CLI trial randomised 1 830 patients with chronic limb threatening ischaemia to ENDO or OPEN revascularisation. Baseline arterial anatomy from case report form data was evaluated using a modified GLASS construct to classify femoropopliteal and infrapopliteal disease severity. Kaplan-Meier analyses and Cox proportional hazards models were used to assess associations between modified GLASS stage, treatment modality, and outcomes including major adverse limb events (MALEs), re-intervention, and amputation.

Results: Modified GLASS stages 1, 2, and 3 were assigned to 12.4%, 24.5%, and 63.1% of trial participants, respectively. The technical failure rate in patients in the ENDO group was 11.1%, 15.4%, and 17.5% in modified GLASS stages 1, 2, and 3, respectively. In ENDO, higher GLASS stage was associated with worse MALE free survival and increased re-intervention risk. No association between GLASS stage and limb based outcomes was observed in OPEN. When comparing ENDO vs. OPEN using Cox models with inverse propensity weighting, OPEN conferred superior limb outcomes in modified GLASS stage 2 and 3 patients, with fewer major re-interventions (hazard ratio [HR] 0.24, 95% confidence interval [CI] 0.15 - 0.40; p < .001 and HR 0.37, 95% CI 0.29 -0.47; p < .001) and amputations (HR 0.57, 95% CI 0.38 - 0.87; p = .009 and HR 0.62 95% CI 0.47 - 0.81; p = .001). Modified GLASS stage was not associated with all cause death in either group.

Conclusion: This study validated GLASS, even in a modified format, as a predictor of limb based outcomes in endovascular therapy and highlighted its limited relevance in predicting outcomes after open bypass. GLASS should be incorporated into clinical decision making and trial designs, particularly to guide the revascularisation strategy in patients with complex occlusive disease (GLASS stage 3).

目的:本研究旨在回顾性应用改良的全球肢体解剖分级系统(GLASS)框架,对参加“重症肢体缺血患者最佳血管内与最佳手术治疗”(Best - cli)试验的患者进行腹股沟下动脉疾病的评估,以评估其对基于肢体的结果的有效性,以及其在指导血管内治疗(ENDO)和开放式手术旁路治疗(open)之间选择的实用性。方法:这是对BEST-CLI临床试验数据集的二次分析。BEST-CLI试验将1830例慢性肢体威胁性缺血患者随机分配至ENDO或OPEN血运重建术。使用改进的GLASS结构对病例报告数据中的基线动脉解剖进行评估,以分类股腘窝和股腘窝下疾病的严重程度。Kaplan-Meier分析和Cox比例风险模型用于评估改良GLASS分期、治疗方式和结局(包括主要肢体不良事件(男性)、再干预和截肢)之间的关联。结果:改良的GLASS阶段1、2和3分别被分配到12%、23%和63%的试验参与者。改良GLASS 1期、2期和3期,ENDO组患者的技术失败率分别为11.1%、15.4%和17.5%。在ENDO中,较高的GLASS分期与较差的MALE无生存期和增加的再干预风险相关。OPEN中未观察到GLASS分期与肢体预后之间的关联。当使用反向倾向加权的Cox模型比较ENDO和OPEN时,OPEN在改良的GLASS 2期和3期患者中具有更好的肢体结局,主要的再干预(风险比[HR] 0.24, 95%可信区间[CI] 0.15 - 0.40; p = 0.000,风险比0.37,95% CI 0.29 -0.47; p = 0.000)和截肢(风险比0.57,95% CI 0.38 - 0.87; p = 0.009,风险比0.62,95% CI 0.47 - 0.81; p = 0.001)较少。改良后的GLASS分期与两组的全因死亡率无关。结论:本研究验证了GLASS,即使是修改后的格式,也可以作为血管内治疗中基于肢体的预后预测指标,并强调了其在预测开放式搭桥术后预后方面的有限相关性。GLASS应纳入临床决策和试验设计,特别是指导复杂闭塞性疾病患者的血运重建策略(GLASS 3期)。
{"title":"Editor's Choice - Association Between Anatomical Patterns of Arterial Occlusive Disease and Endovascular Outcomes in the BEST-CLI Trial Supports the Use of the Global Limb Anatomic Staging System.","authors":"Katharine L McGinigle, Matthew T Menard, Gheorghe Doros, Michael B Strong, Alik Farber, Michael S Conte","doi":"10.1016/j.ejvs.2025.10.039","DOIUrl":"10.1016/j.ejvs.2025.10.039","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to retrospectively apply a modified Global Limb Anatomic Staging System (GLASS) framework of infrainguinal arterial disease to patients enrolled in the Best Endovascular vs. Best Surgical Therapy in patients with Critical Limb Ischemia (BEST-CLI) trial to assess its validity for limb based outcomes and its utility in guiding the choice between endovascular therapy (ENDO) and open surgical bypass (OPEN).</p><p><strong>Methods: </strong>This was a secondary analysis of the BEST-CLI clinical trial dataset. The BEST-CLI trial randomised 1 830 patients with chronic limb threatening ischaemia to ENDO or OPEN revascularisation. Baseline arterial anatomy from case report form data was evaluated using a modified GLASS construct to classify femoropopliteal and infrapopliteal disease severity. Kaplan-Meier analyses and Cox proportional hazards models were used to assess associations between modified GLASS stage, treatment modality, and outcomes including major adverse limb events (MALEs), re-intervention, and amputation.</p><p><strong>Results: </strong>Modified GLASS stages 1, 2, and 3 were assigned to 12.4%, 24.5%, and 63.1% of trial participants, respectively. The technical failure rate in patients in the ENDO group was 11.1%, 15.4%, and 17.5% in modified GLASS stages 1, 2, and 3, respectively. In ENDO, higher GLASS stage was associated with worse MALE free survival and increased re-intervention risk. No association between GLASS stage and limb based outcomes was observed in OPEN. When comparing ENDO vs. OPEN using Cox models with inverse propensity weighting, OPEN conferred superior limb outcomes in modified GLASS stage 2 and 3 patients, with fewer major re-interventions (hazard ratio [HR] 0.24, 95% confidence interval [CI] 0.15 - 0.40; p < .001 and HR 0.37, 95% CI 0.29 -0.47; p < .001) and amputations (HR 0.57, 95% CI 0.38 - 0.87; p = .009 and HR 0.62 95% CI 0.47 - 0.81; p = .001). Modified GLASS stage was not associated with all cause death in either group.</p><p><strong>Conclusion: </strong>This study validated GLASS, even in a modified format, as a predictor of limb based outcomes in endovascular therapy and highlighted its limited relevance in predicting outcomes after open bypass. GLASS should be incorporated into clinical decision making and trial designs, particularly to guide the revascularisation strategy in patients with complex occlusive disease (GLASS stage 3).</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":"284-291"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing Aortic Care: The 2026 European Society for Vascular Surgery (ESVS) Guidelines on Descending Thoracic and Thoraco-abdominal Disease. 推进主动脉护理:2026年欧洲血管外科学会(ESVS)下行胸腹疾病指南。
IF 6.8 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 DOI: 10.1016/j.ejvs.2025.12.043
Bijan Modarai, Luca Bertoglio, Dittmar Böckler
{"title":"Advancing Aortic Care: The 2026 European Society for Vascular Surgery (ESVS) Guidelines on Descending Thoracic and Thoraco-abdominal Disease.","authors":"Bijan Modarai, Luca Bertoglio, Dittmar Böckler","doi":"10.1016/j.ejvs.2025.12.043","DOIUrl":"https://doi.org/10.1016/j.ejvs.2025.12.043","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":"71 2","pages":"165-166"},"PeriodicalIF":6.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Vascular and Endovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1